(Total Views: 220)
Posted On: 01/24/2018 1:56:30 PM
Post# of 72446
I see IPIX has info for patients who may want "expanded access /compassionate use" of (presumably K but maybe also B?).
That,I'm sure,isn't making shorts any more comfortable.
We could still be getting more news on K such as progress on an oral delivery method or expanded info on the latest trial results .
P results are around the corner too with the ever present threat of a BP DEAL looming.for any or all candidates.
Not only the threat of a deal but also the potential SIZE of the DEAL(s).
I don't think anyone has an accurate clue as to how huge the DEAL(s) could be.
We have all seen examples of other "one trick ponies" going from a few bucks to over $100/share with drugs that don't even compare with what IPIX has.Couple that with the fact that IPIX is a "multi,multi trick thoroughbred".
The possibilities are staggering .
Keep playing your games shorts.
Kelt
That,I'm sure,isn't making shorts any more comfortable.
We could still be getting more news on K such as progress on an oral delivery method or expanded info on the latest trial results .
P results are around the corner too with the ever present threat of a BP DEAL looming.for any or all candidates.
Not only the threat of a deal but also the potential SIZE of the DEAL(s).
I don't think anyone has an accurate clue as to how huge the DEAL(s) could be.
We have all seen examples of other "one trick ponies" going from a few bucks to over $100/share with drugs that don't even compare with what IPIX has.Couple that with the fact that IPIX is a "multi,multi trick thoroughbred".
The possibilities are staggering .
Keep playing your games shorts.
Kelt
(2)
(0)
